Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-09

FDA Approved: CARBZAH — Supplemental Application (IPG Pharmaceuticals, inc.)

View source ↗

Summary

FDA approved a supplemental application for CARBZAH (carbinoxamine maleate) from IPG Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBZAH (CARBINOXAMINE MALEATE)

Snippet

SUPPL AP for CARBZAH (CARBINOXAMINE MALEATE)